Market Impact
Dylan Berman
·
April 2, 2025
·
Benzinga
Dylan Berman
·
April 2, 2025
·
Benzinga
Denali Therapeutics, Inc. (NASDAQ:DNLI) shares traded higher on Wednesday after the company initiated its biologics license application (BLA) for the accelerated approval of Tividenofusp Alfa for the treatment of Hunter syndrome.
May 31, 2025
·
Benzinga
May 31, 2025
·
Benzinga
May 20, 2025
·
Financial Times
Copyright © Traders & Quants
